|
Market Closed -
Euronext Bruxelles
11:55:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 220.70 EUR | +0.09% |
|
-0.14% | -7.50% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
EPS & Dividend: UCB
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 1.3 | 1.33 | 1.36 | 1.39 | 1.45 | 1.457 | 1.502 | 1.534 |
| Rate of return | 1.3% | 1.81% | 1.72% | 0.72% | 0.61% | 0.66% | 0.68% | 0.7% |
| EPS 2 | 5.6 | 2.2 | 1.76 | 5.61 | 8.2 | 10.02 | 12.14 | 14.74 |
| Distribution rate | 23.2% | 60.5% | 77.3% | 24.8% | 17.7% | 14.5% | 12.4% | 10.4% |
| Reference price 2 | 100.35 | 73.56 | 78.90 | 192.20 | 238.60 | 220.50 | 220.50 | 220.50 |
| Nbr of stocks (in thousands) | 188,812 | 189,959 | 189,721 | 189,720 | 189,996 | 190,663 | - | - |
| Announcement Date | 2/24/22 | 2/22/23 | 2/28/24 | 2/27/25 | 2/24/26 | - | - | - |
1EUR in Million2EUR
Estimates
Past dividends: UCB
| 2026-05-04 | Ex-dividend date - 1.015 EUR | 00:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.66% | 0.68% | 22.01x | 3.49x | 4.87x | |
| 0.46% | 0.52% | 19.73x | 2.6x | 4.62x | |
| -.--% | -.--% | -17.67x | 10.33x | 26.98x | |
| 2.41% | 2.56% | 20.41x | 3.65x | 4.36x | |
| -.--% | -.--% | 36.57x | 7.38x | 12.46x | |
| -.--% | -.--% | 39.56x | 1.78x | 3.62x | |
| -.--% | -.--% | 57.49x | 4.4x | 3.68x | |
| -.--% | -.--% | 67.86x | 6.91x | 7.21x | |
| -.--% | -.--% | 23.85x | 3.51x | 5.12x | |
| 0.16% | 0.18% | 70.1x | 28.65x | 42.17x | |
| Average | 0.37% | 0.39% | 33.99x | 7.27x | 11.51x | |
| Weighted average by Cap. | 0.52% | 0.56% | 25.29x | 5.82x | 10.19x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
- Stock Market
- Stocks
- UCB Stock
- Valuation UCB
- Dividend
Select your edition
All financial news and data tailored to specific country editions
